NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) Drug Patent Profile
✉ Email this page to a colleague
When do Norethindrone And Ethinyl Estradiol (10/11) patents expire, and when can generic versions of Norethindrone And Ethinyl Estradiol (10/11) launch?
Norethindrone And Ethinyl Estradiol (10/11) is a drug marketed by Watson Labs and Watson Labs Teva and is included in two NDAs.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Clinical Trials: | 41 |
Patent Applications: | 131 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) at DailyMed |
Recent Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Virginia | Early Phase 1 |
Alexion Pharmaceuticals | Phase 1 |
Celerion | Phase 1 |
See all NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)
US Patents and Regulatory Information for NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 071043-001 | Apr 1, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs Teva | NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 071044-001 | Apr 1, 1988 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |